Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2008
09/03/2008CN100415224C Compositions comprising fatty acids and amino acids
09/03/2008CN100415222C Methods of using and compositions comprising dopamine reuptake inhibitors
09/02/2008US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
09/02/2008US7420050 TGF-β-specific covalently closed antisense molecule
09/02/2008US7420029 A tissue-specific transporter function inhibitor has both a ligand structure recognized by a tissue-specific transporter and a polymeric molecular structure incapable of passing through a membrane tissue
09/02/2008US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
09/02/2008US7419999 Gamma lactams as prostaglandin agonists and use thereof
09/02/2008US7419998 Therapeutic methods and compositions involving isoflavones
09/02/2008US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds
09/02/2008US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
09/02/2008US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
09/02/2008US7419970 Cosmetic compositions comprising N-acylamino amides
09/02/2008US7419956 Isolated physiologically active peptide and use thereof
09/02/2008US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation
09/02/2008US7419671 For therapy and prophylaxis of Porphyromonas gingivalis infection
09/02/2008US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant
09/02/2008CA2461757C Nicotine formulations comprising chocolate and use thereof
09/02/2008CA2461517C Nicotine formulations comprising cocoa and use thereof
09/02/2008CA2388140C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
09/02/2008CA2306881C Methods for treating postmenopausal women using ultra-low doses of estrogen
09/02/2008CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent
08/2008
08/28/2008WO2008103847A2 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
08/28/2008WO2008103023A1 Selected colostrum for treatment of intestinal barrier function disorders
08/28/2008WO2008102777A1 Ameliorating agent for insulin resistance
08/28/2008WO2008102749A1 Heterocyclic compound
08/28/2008WO2008102145A2 Process for the preparation of esomeprazole magnesium dihydrate
08/28/2008WO2008102041A1 Composition for treatment of xerostomy or dry mouth
08/28/2008WO2008101428A1 Culture medium for lactobacillus acidophilus and streptococcus faecalis, composition comprising the same and preparation method thereof
08/28/2008WO2008071766A3 Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion
08/28/2008WO2008050344A3 Treatment of hepatic encephalopathy and liver cirrhosis
08/28/2008WO2007072142A3 Benzimidazole-5-carboxamide derivatives
08/28/2008US20080207766 Using N,2,3,3-tetramethylbicyclo92.1.1)heptane-2-amine ; side effect reduction
08/28/2008US20080207764 Novel Benzamidine Derivatives Having Anti-Inflammatory and Immunosuppressive Activity
08/28/2008US20080207758 Reaction product of rhein with bases or amino acids; antidiabetic agents; gastrointestinal disorders; antiarthritic agents
08/28/2008US20080207754 Method and apparatus for palatable prevention of acid reflux
08/28/2008US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents
08/28/2008US20080207749 Gastrointestinal disorders; urogenital disorders
08/28/2008US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound
08/28/2008US20080207730 Methods of using (+)-2-[1-(3-Ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione
08/28/2008US20080207690 Benzisoxazole Derivatives
08/28/2008US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
08/28/2008US20080207675 Aqueous Gel Formulations Containing 1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine
08/28/2008US20080207669 (S)-N-Stereoisomers of 7,8-Saturated-4,5-Epoxy-Morphinanium Analogs
08/28/2008US20080207655 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/28/2008US20080207646 Prevent collagen synthesis in liver cells; increase blood flow through portal vein; cirrhosis; long half-life
08/28/2008US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents
08/28/2008US20080207633 Conjugated to polyoxyethylene glycol; analgesics; antidiabetic agents; anticancer agents; sleep disorders; antidepressants; anxiolytic agents
08/28/2008US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/28/2008US20080207612 Analgesics; pain management
08/28/2008US20080207579 Uses of tetrahydrobiopterin and derivatives thereof
08/28/2008US20080207569 Methods for the treatment of liver diseases
08/28/2008US20080207564 Derivaitves of 4-Or 5-Aminosalicylic Acid
08/28/2008US20080207559 Carbohydrates mixture
08/28/2008US20080207530 Tritoqualine or isomer, alpha-fluoromethylhistidine, 3-methoxy-5,7,3',4'-tetrahydroxyflavan, naringenin, cyanidanol-3, His-Phe dipeptide, 4-imidazolyl-3-amino-2-butanone, epigallocatechin gallate and other catechins;
08/28/2008US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies
08/28/2008US20080207493 Moderator of melanocortin receptor ; delay diabetes
08/28/2008US20080206348 Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers
08/28/2008US20080206333 Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
08/28/2008US20080206275 fucoxanthin in pure form or as a component of a brown marine vegetable extract; pomegranate seed oil
08/28/2008US20080206267 Inactivation Of Genes Of The Mep Pathway
08/28/2008US20080206261 administering RegIII protein or Ins2 protein; expression of the IBD marker was decreased
08/28/2008US20080206257 Reducing epithelial toxicity during cancer therapy by administering KGF with e.g. erlotinib, Iressa(TM), canertinib, or a monoclonal antibody against EGFR; side effect reduction of diarrhea, rash
08/28/2008US20080206145 Gastro-Retentive Diagnostic Assemblies
08/28/2008DE10164893B4 Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte Process for the preparation of artichoke leaf extracts and extracts so obtained artichoke leaves
08/28/2008CA2678757A1 Ameliorating agent for insulin resistance
08/28/2008CA2678702A1 Process for the preparation of esomeprazole magnesium dihydrate
08/28/2008CA2677854A1 Composition for treating xerostomia or dry mouth
08/27/2008EP1961811A1 Novel cytokine ZCYTOR17 ligand
08/27/2008EP1961771A1 Bismuth hyaluronate, the preparation method and the use theirof
08/27/2008EP1961768A1 Recombinant IL-18 Antibodies useful in Treatment of IL-18 mediated Disorders
08/27/2008EP1961767A2 Diagnosis and treatment of cancers and other conditions
08/27/2008EP1961756A1 Novel bisboron compound
08/27/2008EP1961754A1 Bicyclic heterocyclic compound
08/27/2008EP1961745A1 Bicyclic heterocyclic compound
08/27/2008EP1961311A1 Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
08/27/2008EP1960401A1 Tricyclic amide derivatives useful for treating obesity
08/27/2008EP1960397A2 Crystalline forms of palonosetron hydrochloride
08/27/2008EP1960396A2 Carbamate compounds as 5-ht4 receptor agonists
08/27/2008EP1960390A1 Biaryl compounds useful as agonists of the gpr38 receptor
08/27/2008EP1960384A1 New process for the preparation of esomeprazole non-salt form
08/27/2008EP1959982A1 Methods and compositions for preventing and/or treating pancreatitis
08/27/2008EP1959970A1 Use of a polysaccharide which is excreted by the vibrio dlabolicus species for the regeneration and protection of the periodontium
08/27/2008EP1959943A1 Orally administered antibiotics for the treatment of hemorrhoids
08/27/2008EP1858881B1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol
08/27/2008EP1596810B1 Use of banana extract for the treatment of inflammatory bowel disease
08/27/2008EP1474146B1 Phenylpyrimidine amines as ige inhibitors
08/27/2008EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
08/27/2008EP1406895B1 Lactone formulations and method of use
08/27/2008EP1337560B1 Truncated cd200
08/27/2008EP1234025B1 Human enzymes of the metalloprotease family
08/27/2008EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease
08/27/2008CN101252947A Nutrient composition
08/27/2008CN101252939A Steroidal glycoside compounds as core 2N-glcnac-t inhibitors
08/27/2008CN101252934A Prokineticin 1 receptor
08/27/2008CN101250207A Canton love-pea vine total flavone c-glycosides effective part, preparation method and use thereof
08/27/2008CN101250183A Optical isomer of rebeprazole as well as preparation method and medical use thereof
08/27/2008CN101250182A Lansoprazole sodium
08/27/2008CN101250181A S-pantoprazole sodium
08/27/2008CN101250180A Amorphous S-pantoprazole sodium, preparation method and use thereof
08/27/2008CN101249296A Navel curing machine